PrimeInvestor - Articles and Reports

Moving-this-biotech-stock-from-BUY-to-a-HOLD
Stocks
N V Chandrachoodamani

Prime Stocks update: Moving this biotech stock from BUY to a HOLD

When we gave the call of this R&D focused company engaged in the manufacture of enzymes and probiotics, the company had Covid-related challenges but showed promise of growth. It was later also pulled down by consolidation of acquisitions and costs related to new product launches. We therefore knew that the call would take longer to pay off.ย  The stock went through a significant correction after our initial recommendation as earnings disappointed.

Premium article available only to subscribers.

Read More
Prime Stocks Update - How this EV player is placed now
Stocks
N V Chandrachoodamani

Prime Stocks update: How this EV player is placed now

We had, in mid-2021, initiated a buy call on a stock that was reinventing itself from a supplier of diesel engines into an EV player. It was an early call weโ€™d made on the EV boom, which appears well-timed as electric 2-wheeler sales jumped from 16,000 units in 2018 to 150,000 units in 2021 to a whopping 615,000 units in 2022!
With the EV 2-wheeler market now clearly segmenting itself, there is more clarity on how competition and market share is shaping up. The EV 2-wheeler industry is also going through regulatory tightening.

Premium article available only to subscribers.

Read More
Prime Stocks - An update on a recommendation
Stocks
N V Chandrachoodamani

Prime Stocks: An update on a recommendation

In one of our stock recommendations last year, we analysed a company that was moving from โ€˜tonnage to technologyโ€™. We spoke briefly about the company transforming itself from a manufacturer of forged components to a supplier of products, systems and assemblies to defence and electric vehicles. The stock delivered 27% since our call (index 8.5%) and we retain a buy. In this report we detail further on the above opportunities based on the information that the company shared with analysts last month.

Premium article available only to subscribers.

Read More
5 reasons to avoid PSU ETFs
Mutual funds & ETFs
Aarati Krishnan

5 reasons to avoid PSU ETFs

The list of top performing equity funds for the past year features a couple of unusual entries. With a return of 18-21 per cent, CPSE ETF (managed by Nippon India Mutual Fund for the government of India) and the Bharat 22 ETF (managed by ICICI Prudential Mutual Fund) are top rankers among equity funds.
This has many investors asking if they should add these passive funds to their portfolio. The portfolios of CPSE and Bharat 22 ETFs are made up of the PSU oil, energy and financial giants which are the flavour of the season. These ETFsโ€™ costs are ultra-low because they are used as divestment vehicles. Both ETFs would also seem to be โ€˜value buysโ€™ if you go by their ultra-cheap valuations. The CPSE ETF trades at a portfolio PE of 7 times and Bharat 22 ETF at about 11 times. This is a fraction of the current Nifty50 PE at over 21 times.
But does this make them worth betting on? There are five good reasons for long-term stock investors to steer clear of these ETFs.

Read More
PRIME EQUITY OUTLOOK 2023
Markets
N V Chandrachoodamani

Prime Equity Outlook 2023

In our Prime Equity outlook in 2022 we said โ€œWe would expect any correction triggered by global rates to take the Nifty 50 down to the 12,500 to 15,000 range. In this range, investors should deploy cash and swoop in on buying opportunities rather than develop cold feet!โ€.
The equity market world over did see a correction in 2022 along these lines and as geo-political factors took hold. Indian markets too, experienced a rout in the first half of the year hitting close to our predicted range at 15,200 by mid-June.
Even so, India did a lot better than its emerging market peers. The Nifty 50 closed the year on a positive note, with a modest 4% return. Simply buying the Nifty 50 would have delivered a good 18% from June until December 2022. Our own stock picks delivered well in 2022, too.
But with global recession on the cards, still high Nifty 50 and a hostile rate scenario, can 2023 be better than 2022? For Indian markets, there are some key trends that we think can play out. We look at where the Nifty 50 could be headed, and where opportunities lie.

Read More
Prime Stocks performance review 2022
Stocks
PrimeInvestor Research Team

Prime Stocks performance review 2022

In this report, we look at the hits and misses of our Prime Stock calls this year and what we will do to add more value next year.ย 

Read More
IPO Review Sula Vineyards
Stocks
N V Chandrachoodamani

IPO Review: Should you take a sip of the Sula Vineyards IPO?

Sula Vineyards is launching an IPO worth Rs 960 crore, consisting solely of an offer for sale by investors including a 1% stake sale by the promoter. The offer for sale will result in approximately 32% of equity being sold by the selling shareholders with the promoter stake at ~28% post-issue. The issue opens on December 12 and closes on December 14. Shares are being offered at a price band of Rs.340-Rs.357 per share of face value Rs 2. This being an offer for sale, the company will not receive any funds from the issue.

Read More
Debt fund strategies for the current rate scenario
Strategies
Bhavana Acharya

Debt fund strategies for the current rate scenario

The Reserve Bankโ€™s monetary policy on Wednesday served up another repo rate hike of 35 basis points, adding to the 190 basis points through this year. That takes the repo rate to 6.25% from the Covid low of 4%. The key driving factor behind the rapid rate hikes โ€“ that of inflation โ€“ still remains. The RBI has clearly spelt its commitment to bringing inflation within the target range, even in its latest monetary policy.
In this light, debt fund strategies you have now, to make the most of the current scenario, can be decided based on what you want:

Read More
An AT1 Bond with high yield
Bonds & Deposits
Aarati Krishnan

Prime Bond recommendation: An AT1 bond with high yield

At PrimeInvestor, we took an ultra-conservative approach to debt investments during Covid and just after it. But with economic recovery taking root, interest rates rising and credit offtake improving, we believe investors can shoot for higher yields by taking on some credit risk. Perpetual bonds from banks with sound financials are one option, offering good reward for risks taken. We are covering one such bond here.

Read More
Stock review : An under-researched, niche, small-cap play
Stocks
Vidya Bala

Stock review : An under-researched, niche, small-cap play

A lot goes into making that piece of gold jewellery you see at your jewellersโ€™. Or even the copper that goes into your two-and four-wheelers. The first step starts with mining these metal and mineral ores. The next is to crush the ore lumps into desired sizes and processing them in mills to extract the metal or mineral.ย This involves a lot of machinery such as crushers, screens and other mineral processing equipment. In mill equipment, thereโ€™s a critical component that protects the equipment to ensure longer life, reduce noise as well as downtime, and improve safety.ย 

Read More
Use this passive fund for your large-and-midcap exposure
Recommendations
Bhavana Acharya

Use this passive fund for your large-and-midcap exposure

A few weeks ago, we had written in detail the categories in which we think passive funds have become a necessity to keep your portfolio returns stable; even if you hold active funds. We made this call as performance of active funds were becoming relatively more inconsistent, in a few key categories.

Read More
Should you still bank on banking stocks? Earnings review and more
Stocks
N V Chandrachoodamani

Should you still bank on banking stocks? Earnings review and more

This earnings season, the standout performers come from the banking sector. While private banks led the revival in earlier quarters, this time around, performance is visible all round โ€“ across leading private banks to old private banks and PSU banks.

Read More
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

or
Have an account?
Login To Your Account
OR
Donโ€™t have an account ? Register for free